KRAS and metastatic malignant neoplasm in the lymph nodes: Tjensvoll et al. reported that changes in the levels of KRAS ctDNA in the circulation correlated with the levels of CA19-9 during chemotherapy50, suggesting that extraordinarily high CA19-9 levels may represent micrometastasis, including lymph node metastasis, which is difficult to detect via imaging studies before surgery.